HU9603631D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
HU9603631D0
HU9603631D0 HU9603631A HUP9603631A HU9603631D0 HU 9603631 D0 HU9603631 D0 HU 9603631D0 HU 9603631 A HU9603631 A HU 9603631A HU P9603631 A HUP9603631 A HU P9603631A HU 9603631 D0 HU9603631 D0 HU 9603631D0
Authority
HU
Hungary
Prior art keywords
pct
sec
pharmaceutical compositions
date
pub
Prior art date
Application number
HU9603631A
Other languages
English (en)
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Priority to HU9603631A priority Critical patent/HU225149B1/hu
Publication of HU9603631D0 publication Critical patent/HU9603631D0/hu
Priority to PCT/HU1997/000090 priority patent/WO1998029103A2/en
Priority to CN97192641A priority patent/CN1116872C/zh
Priority to ES97952124T priority patent/ES2181051T3/es
Priority to JP10529762A priority patent/JP2000505819A/ja
Priority to CA002244907A priority patent/CA2244907C/en
Priority to PT97952124T priority patent/PT930879E/pt
Priority to US09/117,830 priority patent/US5994411A/en
Priority to AT97952124T priority patent/ATE223211T1/de
Priority to EP97952124A priority patent/EP0930879B1/en
Priority to DE69715227T priority patent/DE69715227D1/de
Publication of HUP9603631A2 publication Critical patent/HUP9603631A2/hu
Publication of HUP9603631A3 publication Critical patent/HUP9603631A3/hu
Publication of HU225149B1 publication Critical patent/HU225149B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU9603631A 1996-12-30 1996-12-30 Use of dobesilate salts for the manufacture of medicaments for the treatment or prevention of embryonic retardation or discordance HU225149B1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
HU9603631A HU225149B1 (en) 1996-12-30 1996-12-30 Use of dobesilate salts for the manufacture of medicaments for the treatment or prevention of embryonic retardation or discordance
DE69715227T DE69715227D1 (de) 1996-12-30 1997-12-30 Verwendung von kalzium dobesilat zur herstellung eines arzneimittels zur behandlung von embryonaler zurückgebliebenheit
CN97192641A CN1116872C (zh) 1996-12-30 1997-12-30 制剂产品
PCT/HU1997/000090 WO1998029103A2 (en) 1996-12-30 1997-12-30 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation
ES97952124T ES2181051T3 (es) 1996-12-30 1997-12-30 Derivados del acido 2,5-dihidroxi-benceno sulfonico para la fabricacion de medicamentos para la prevencion o el tratamiento del atraso embrionario.
JP10529762A JP2000505819A (ja) 1996-12-30 1997-12-30 製剤製品
CA002244907A CA2244907C (en) 1996-12-30 1997-12-30 Formulated product
PT97952124T PT930879E (pt) 1996-12-30 1997-12-30 Utilizacao de dobesilato de calcio para a preparacao de um medicamento para o tratamento de retardamento embrionario
US09/117,830 US5994411A (en) 1996-12-30 1997-12-30 Formulated product for embryonic retardation or discordance
AT97952124T ATE223211T1 (de) 1996-12-30 1997-12-30 Verwendung von kalzium dobesilat zur herstellung eines arzneimittels zur behandlung von embryonaler zurückgebliebenheit
EP97952124A EP0930879B1 (en) 1996-12-30 1997-12-30 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9603631A HU225149B1 (en) 1996-12-30 1996-12-30 Use of dobesilate salts for the manufacture of medicaments for the treatment or prevention of embryonic retardation or discordance

Publications (4)

Publication Number Publication Date
HU9603631D0 true HU9603631D0 (en) 1997-02-28
HUP9603631A2 HUP9603631A2 (hu) 1998-09-28
HUP9603631A3 HUP9603631A3 (en) 1999-06-28
HU225149B1 HU225149B1 (en) 2006-07-28

Family

ID=89994597

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9603631A HU225149B1 (en) 1996-12-30 1996-12-30 Use of dobesilate salts for the manufacture of medicaments for the treatment or prevention of embryonic retardation or discordance

Country Status (10)

Country Link
US (1) US5994411A (hu)
EP (1) EP0930879B1 (hu)
JP (1) JP2000505819A (hu)
CN (1) CN1116872C (hu)
AT (1) ATE223211T1 (hu)
DE (1) DE69715227D1 (hu)
ES (1) ES2181051T3 (hu)
HU (1) HU225149B1 (hu)
PT (1) PT930879E (hu)
WO (1) WO1998029103A2 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2180446B1 (es) * 2001-07-02 2004-01-16 Esteve Labor Dr Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6163M (hu) * 1966-01-20 1968-07-08

Also Published As

Publication number Publication date
PT930879E (pt) 2003-01-31
CN1232390A (zh) 1999-10-20
ES2181051T3 (es) 2003-02-16
HUP9603631A3 (en) 1999-06-28
DE69715227D1 (de) 2002-10-10
WO1998029103A3 (en) 1998-08-27
HU225149B1 (en) 2006-07-28
ATE223211T1 (de) 2002-09-15
WO1998029103A2 (en) 1998-07-09
HUP9603631A2 (hu) 1998-09-28
JP2000505819A (ja) 2000-05-16
CN1116872C (zh) 2003-08-06
EP0930879B1 (en) 2002-09-04
US5994411A (en) 1999-11-30
EP0930879A2 (en) 1999-07-28

Similar Documents

Publication Publication Date Title
PT1465626E (pt) Composições farmacêuticas (kit) que compreendem compostos di-hidropiridinona e um agente imunorregulador (ou antiinflamatório) e suas utilizações
LU91145I9 (hu)
CA2449729A1 (en) Prodrugs of gaba analogs, compositions and uses thereof
DE69528829T2 (de) Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
AU5242000A (en) Nematicidal trifluorobutenes
DE69725608D1 (de) Indolin-2-one derivate, verfahren zu ihrer herstellung und dieseenthaltende arzneimittel
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
MX9601360A (es) Mezcla estabilizante sinergistica.
YU29601A (sh) Novi estri izvedeni iz supstituisanih fenil-cikloheksil jedinjenja
BG102259A (en) Compostions with controlled paroxetine release
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
GB9712966D0 (en) Novel chalcones
GB9907571D0 (en) Compounds
DE69715173D1 (en) Bisarylcyclobutenderivate als cyclooxygenasehemmer
PL370361A1 (en) Alkyl urea retinoid agonists i
AU1469097A (en) Pharmaceutical compounds
HU9603631D0 (en) Pharmaceutical compositions
MY121344A (en) Formulated product
BG104452A (en) New derivatives of the methylenebisphosphonic acid
SI1077694T1 (en) Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
BR0214244A (pt) Uso de uma ascomicina
NZ505085A (en) Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
MX9703610A (es) Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.
SE9501773D0 (sv) New use

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: DR. BEDOE TIBOR, HU

Free format text: FORMER OWNER(S): BIOGAL GYOGYSZERGYAR RT., HU; DR. VOJCEK LASZLO, HU; BIOGAL GYOGYSZERGYAR RT., HU

Owner name: DR. VOJCEK LASZLO, HU

Free format text: FORMER OWNER(S): BIOGAL GYOGYSZERGYAR RT., HU; DR. VOJCEK LASZLO, HU; BIOGAL GYOGYSZERGYAR RT., HU

Owner name: TEVA GYOGYSZERGYAR ZRT., HU

Free format text: FORMER OWNER(S): BIOGAL GYOGYSZERGYAR RT., HU; DR. VOJCEK LASZLO, HU; BIOGAL GYOGYSZERGYAR RT., HU

FH92 Termination of representative

Representative=s name: EMRI-PATENT KFT., HU